Amended Statement of Beneficial Ownership (sc 13d/a)
June 15 2022 - 06:41AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Schedule
13D
Under the Securities Exchange Act of 1934
(Amendment No. 7)
GLOBAL
CORD BLOOD CORPORATION
(Name of Issuer)
Ordinary Shares, $0.0001 par value
(Title of Class of
Securities)
G21107100
(CUSIP Number)
Cheng Zeng
No. 68 Software
Avenue, Yuhuatai District
Nanjing, China
+86-25-83274734 |
(Name, Address
and Telephone Number of Person Authorized to Receive Notices and
Communications)
June 15, 2022
(Date of Event
Which Requires Filing of this Statement)
If
the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D,
and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ¨
Note:
Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7
for other parties to whom copies are to be sent.
|
* |
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. |
The information required on the remainder of this cover page shall
not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
1. |
NAME OF REPORTING PERSON:
Blue Ocean Structure Investment
Co Ltd |
2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨
(b) ¨ |
3. |
SEC USE ONLY |
4. |
SOURCE OF FUNDS
AF |
5. |
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e): ¨ |
6. |
CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH REPORTING
PERSON
WITH |
7. |
SOLE VOTING POWER
0 |
8. |
SHARED VOTING POWER
79,528,662 |
9. |
SOLE DISPOSITIVE POWER
0 |
10. |
SHARED DISPOSITIVE POWER
79,528,662 |
11. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
79,528,662 |
12. |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
EXCLUDES
CERTAIN SHARES
¨ |
13. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
(11)
65.4%(1)
|
14. |
TYPE OF REPORTING PERSON
CO |
|
|
|
|
(1) Based
on 121,551,075 shares outstanding as of December 31, 2021 pursuant to the Issuer’s Form 6-K filed with the SEC on February 28,
2022.
1. |
NAME OF REPORTING PERSON:
Nanjing Ying Peng Hui Kang Medical
Industry Investment Partnership (Limited Partnership) |
2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨
(b) ¨ |
3. |
SEC USE ONLY |
4. |
SOURCE OF FUNDS
OO |
5. |
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e): ¨ |
6. |
CITIZENSHIP OR PLACE OF ORGANIZATION
Peoples Republic of China |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH REPORTING
PERSON
WITH |
7. |
SOLE VOTING POWER
0 |
8. |
SHARED VOTING POWER
79,528,662 |
9. |
SOLE DISPOSITIVE POWER
0 |
10. |
SHARED DISPOSITIVE POWER
79,528,662 |
11. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
79,528,662 |
12. |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES
x |
13. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
(11)
65.4%(2)
|
14. |
TYPE OF REPORTING PERSON
PN |
|
|
|
|
(2) Based
on 121,551,075 shares outstanding as of December 31, 2021 pursuant to the Issuer’s Form 6-K filed with the SEC on February 28,
2022.
1. |
NAME OF REPORTING PERSON:
Nanjing Ying Peng Asset Management
Co., Ltd. |
2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨
(b) ¨ |
3. |
SEC USE ONLY |
4. |
SOURCE OF FUNDS
AF |
5. |
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e): ¨ |
6. |
CITIZENSHIP OR PLACE OF ORGANIZATION
People’s Republic of China |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH REPORTING
PERSON
WITH |
7. |
SOLE VOTING POWER
0 |
8. |
SHARED VOTING POWER
79,528,662 |
9. |
SOLE DISPOSITIVE POWER
0 |
10. |
SHARED DISPOSITIVE POWER
79,528,662 |
11. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
79,528,662 |
12. |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES
x |
13. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
(11)
65.4%(3)
|
14. |
TYPE OF REPORTING PERSON
CO |
|
|
|
|
(3) Based
on 121,551,075 shares outstanding as of December 31, 2021 pursuant to the Issuer’s Form 6-K filed with the SEC on February 28,
2022.
1. |
NAME OF REPORTING PERSON:
Yafei Yuan |
2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨
(b) ¨ |
3. |
SEC USE ONLY |
4. |
SOURCE OF FUNDS
OO |
5. |
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e): ¨ |
6. |
CITIZENSHIP OR PLACE OF ORGANIZATION
People’s Republic of China |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH REPORTING
PERSON
WITH |
7. |
SOLE VOTING POWER
0 |
8. |
SHARED VOTING POWER
81,528,662 |
9. |
SOLE DISPOSITIVE POWER
0 |
10. |
SHARED DISPOSITIVE POWER
81,528,662 |
11. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
81,528,662 |
12. |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES
¨ |
13. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
(11)
67.1%(4)
|
14. |
TYPE OF REPORTING PERSON
IN |
|
|
|
|
(4) Based
on 121,551,075 shares outstanding as of December 31, 2021 pursuant to the Issuer’s Form 6-K filed with the SEC on February 28,
2022.
1. |
NAME OF REPORTING PERSON:
Dendreon Pharmaceuticals LLC |
2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨
(b) ¨ |
3. |
SEC USE ONLY |
4. |
SOURCE OF FUNDS
OO |
5. |
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e): ¨ |
6. |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH REPORTING
PERSON
WITH |
7. |
SOLE VOTING POWER
0 |
8. |
SHARED VOTING POWER
2,000,000 |
9. |
SOLE DISPOSITIVE POWER
0 |
10. |
SHARED DISPOSITIVE POWER
2,000,000 |
11. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
2,000,000 |
12. |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES
¨ |
13. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
(11)
1.6%(5)
|
14. |
TYPE OF REPORTING PERSON
OO |
|
|
|
|
(5) Based
on 121,551,075 shares outstanding as of December 31, 2021 pursuant to the Issuer’s Form 6-K filed with the SEC on February 28,
2022.
1. |
NAME OF REPORTING PERSON:
Nanjing Xinjiekou Department Store Co., Ltd. |
2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨
(b) ¨ |
3. |
SEC USE ONLY |
4. |
SOURCE OF FUNDS
OO |
5. |
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e): ¨ |
6. |
CITIZENSHIP OR PLACE OF ORGANIZATION
People’s Republic of China |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH REPORTING
PERSON
WITH |
7. |
SOLE VOTING POWER
0 |
8. |
SHARED VOTING POWER
2,000,000 |
9. |
SOLE DISPOSITIVE POWER
0 |
10. |
SHARED DISPOSITIVE POWER
2,000,000 |
11. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
2,000,000 |
12. |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES
¨ |
13. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
(11)
1.6%(6)
|
14. |
TYPE OF REPORTING PERSON
CO |
|
|
|
|
(6) Based
on 121,551,075 shares outstanding as of December 31, 2021 pursuant to the Issuer’s Form 6-K filed with the SEC on February 28,
2022.
1. |
NAME OF REPORTING PERSON:
Sanpower Group Co., Ltd. |
2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ¨
(b) ¨ |
3. |
SEC USE ONLY |
4. |
SOURCE OF FUNDS
OO |
5. |
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e): ¨ |
6. |
CITIZENSHIP OR PLACE OF ORGANIZATION
People’s Republic of China |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH REPORTING
PERSON
WITH |
7. |
SOLE VOTING POWER
0 |
8. |
SHARED VOTING POWER
81,528,662 |
9. |
SOLE DISPOSITIVE POWER
0 |
10. |
SHARED DISPOSITIVE POWER
81,528,662 |
11. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
81,528,662 |
12. |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES
¨ |
13. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
(11)
67.1%(5)
|
14. |
TYPE OF REPORTING PERSON
CO |
|
|
|
|
(5) Based
on 121,551,075 shares outstanding as of December 31, 2021 pursuant to the Issuer’s Form 6-K filed with the SEC on February 28,
2022.
INTRODUCTORY NOTE
This Amendment No. 7 to Schedule 13D (this “Amendment
No. 7”) relates to the Schedule 13D filed on February 8, 2018, as amended prior to this Amendment No. 7 (as
so amended, the “Schedule 13D”) with respect to the ordinary shares, par value $0.0001 per share (the “Shares”),
of Global Cord Blood Corporation, an exempted company incorporated under the laws of the Cayman Islands (the “Issuer”).
Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable. Except as otherwise
specified in this Amendment No. 7, all items in the Schedule 13D are unchanged. All capitalized terms used in this Amendment No. 7
and not otherwise defined herein have the meaning ascribed to such terms in the Schedule 13D.
ITEM 4. |
PURPOSE OF TRANSACTION |
The following paragraph is added as the penultimate paragraph of Item
4 of the Schedule 13D:
In connection with the EGM to be held
on June 16, 2022, individuals seeking to attend must comply with the rules of conduct (the “Rules”). The
Rules are attached hereto as Exhibit A and are incorporated herein by reference.
ITEM 7. |
MATERIAL TO BE FILED AS EXHIBITS |
Exhibit A – Rules
|
Blue Ocean Structure Investment Co Ltd |
|
|
|
By: |
/s/ Xiaoyang Chen |
|
Name: Xiaoyang Chen |
|
Title: Director |
|
|
|
Nanjing Ying Peng Hui Kang Medical
Industry Investment Partnership (Limited Partnership) |
|
|
|
By: |
/s/ Lei Wang |
|
Name: Lei Wang |
|
Title: Authorized Signatory |
|
|
|
Nanjing Ying Peng Asset Management Co., Ltd. |
|
|
|
By: |
/s/ Lei Wang |
|
Name: Lei Wang |
|
Title: Executive Director |
|
|
|
YAFEI YUAN |
|
|
|
By: |
/s/ Yafei Yuan |
|
Name: Yafei YUAN |
|
|
|
DENDREON PHARMACEUTICALS LLC |
|
|
|
By: |
/s/ Yong Zhang |
|
Name: Yong Zhang |
|
Title: Chief Executive Officer |
|
|
|
NANJING XINJIEKOU DEPARTMENT STORE CO., LTD. |
|
|
|
By: |
/s/ Lingyun Zhai |
|
Name: Lingyun Zhai |
|
Title: Chairman of the Board |
|
|
|
SANPOWER GROUP CO., LTD. |
|
|
|
By: |
/s/ Yafei Yuan |
|
Name: Yafei Yuan |
|
Title: Chairman of the Board |
EXHIBIT A
RULES
Global Cord Blood (NYSE:CO)
Historical Stock Chart
From Feb 2024 to Mar 2024
Global Cord Blood (NYSE:CO)
Historical Stock Chart
From Mar 2023 to Mar 2024